Hepatitis B in men is a liver disease caused by infection with the hepatitis B virus. The severity varies from person to person, and some patients may develop cirrhosis or liver cancer. Treatment includes antiviral drugs such as entecavir and tenofovir, hepatoprotective drugs such as silymarin and glycyrrhizic acid, and regular monitoring of liver function. Preventive measures include hepatitis B vaccination, avoiding unsafe sexual practices, and avoiding sharing needles.
1. Hepatitis B virus is transmitted through blood and bodily fluids. Men infected may experience symptoms such as fatigue, loss of appetite, and jaundice. Long-term infection can lead to liver fibrosis, cirrhosis, and even liver cancer. Early diagnosis and treatment are crucial for controlling the disease.
2. Antiviral therapy is the core of hepatitis B management. Commonly used drugs include entecavir, tenofovir, and lamivudine. These drugs can effectively inhibit viral replication and reduce liver damage. Hepatoprotective drugs such as silymarin, compound glycyrrhizin, and glutathione help improve liver function and alleviate symptoms.
3. Regular monitoring of liver function is an important part of hepatitis B patient management, including liver function tests, hepatitis B virus DNA quantification, and liver ultrasound. These tests help assess disease progression and treatment effectiveness, allowing for timely adjustments to the treatment plan.
4. The key to preventing hepatitis B is vaccination, especially for high-risk groups such as healthcare workers, sex workers, and intravenous drug users. Avoiding unsafe sexual practices, sharing syringes, and using unsterilized medical instruments can also effectively reduce the risk of infection.
The severity of hepatitis B in men depends on individual circumstances and the timeliness of treatment. With standardized antiviral therapy, liver-protective drugs, and regular monitoring, most patients can effectively control their condition and reduce the occurrence of complications. Active prevention and early intervention are key to reducing the harm of hepatitis B.